Atlas Trials

Impact of SomaSignal Tests on the Choice of Glucose-lowering Medications

Clinical trial NCT05166382 · COMPLETED

Trial details

NCT number
NCT05166382
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 DiabetesCardiovascular Diseases
Start date
2022-01-01
Primary completion
2024-01-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.